• Article metrics
  • Last updated: Thu, 9 Oct 2025 5:09:46 Z

Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Access & Citations

  • 7020
    Article Accesses
  • 3
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 19
  • 22 tweeters
  • 1 news outlets
  • 6 Mendeley

This article is in the 92nd percentile (ranked 25,314th) of the 329,285 tracked articles of a similar age in all journals and the 82nd percentile (ranked 17th) of the 99 tracked articles of a similar age in Signal Transduction and Targeted Therapy

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.

Mentions in news and blogs

This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.